364 related articles for article (PubMed ID: 27824701)
21. Mixed adenoneuroendocrine carcinomas of stomach and ampulla of vater after curative-intent resection: a single center cases series.
Yang S; Lu J; Cai Y; Li B; Xiong X
BMC Gastroenterol; 2021 Aug; 21(1):329. PubMed ID: 34433421
[TBL] [Abstract][Full Text] [Related]
22. Mixed adenoneuroendocrine carcinoma of the ampulla: two case reports.
Huang Z; Xiao WD; Li Y; Huang S; Cai J; Ao J
World J Gastroenterol; 2015 Feb; 21(7):2254-9. PubMed ID: 25717267
[TBL] [Abstract][Full Text] [Related]
23. Two patients with rare mixed adenoneuroendocrine carcinomas of the rectum.
Gül-Klein S; Sinn M; Jurmeister PS; Biebl M; Weiß S; Rau B; Bläker H; Pratschke J; Aigner F
SAGE Open Med Case Rep; 2018; 6():2050313X18758816. PubMed ID: 29568525
[TBL] [Abstract][Full Text] [Related]
24. Mixed Adenoneuroendocrine Carcinoma, Amphicrine Type, of the Small Bowel.
Ludmir EB; McCall SJ; Cardona DM; Perkinson KR; Guy CD; Zhang X
Am J Clin Pathol; 2016 May; 145(5):703-9. PubMed ID: 27124941
[TBL] [Abstract][Full Text] [Related]
25. Diagnosis, Assessment, and Therapeutic Strategy for Colorectal Mixed Adenoneuroendocrine Carcinoma.
Tanaka T; Kaneko M; Nozawa H; Emoto S; Murono K; Otani K; Sasaki K; Nishikawa T; Kiyomatsu T; Hata K; Morikawa T; Kawai K; Watanabe T
Neuroendocrinology; 2017; 105(4):426-434. PubMed ID: 28641295
[TBL] [Abstract][Full Text] [Related]
26. Mixed adenoneuroendocrine carcinoma of the non-ampullary duodenum with mismatch repair deficiency: a rare case report.
Nozawa Y; Ishida K; Maiko N; Takada-Owada A; Onozaki M; Takaoka M; Matsuyama K; Sakuraoka Y; Nakazato Y; Kubota K
Med Mol Morphol; 2022 Sep; 55(3):258-266. PubMed ID: 35596001
[TBL] [Abstract][Full Text] [Related]
27. Mixed Adenoneuroendocrine Carcinoma (MANEC) of the Gallbladder: A Systematic Review of Outcomes Following Surgical Management.
Machairas N; Paspala A; Frountzas M; Tsilimigras DI; Moris D; Ntomi V; Tsapralis D; Schizas D
In Vivo; 2019; 33(6):1721-1726. PubMed ID: 31662496
[TBL] [Abstract][Full Text] [Related]
28. Neuroendocrine carcinoma of the stomach: morphologic and immunohistochemical characteristics and prognosis.
Ishida M; Sekine S; Fukagawa T; Ohashi M; Morita S; Taniguchi H; Katai H; Tsuda H; Kushima R
Am J Surg Pathol; 2013 Jul; 37(7):949-59. PubMed ID: 23759931
[TBL] [Abstract][Full Text] [Related]
29. Chromogranin A-, serotonin-, synaptophysin- and vascular endothelial growth factor-positive endocrine cells and the prognosis of colorectal cancer: an immunohistochemical and ultrastructural study.
Gulubova M; Vlaykova T
J Gastroenterol Hepatol; 2008 Oct; 23(10):1574-85. PubMed ID: 18771509
[TBL] [Abstract][Full Text] [Related]
30. [Clinicopathological features of pancreatic neuroendocrine neoplasms: a retrospective analysis of 64 cases].
Yao W; Wang W; Li G
Zhonghua Zhong Liu Za Zhi; 2014 Apr; 36(4):287-93. PubMed ID: 24989916
[TBL] [Abstract][Full Text] [Related]
31. Primary signet ring cell carcinoma of colorectum: an age- and sex-matched controlled study.
Tung SY; Wu CS; Chen PC
Am J Gastroenterol; 1996 Oct; 91(10):2195-9. PubMed ID: 8855747
[TBL] [Abstract][Full Text] [Related]
32. Neuroendocrine carcinomas of the colon and rectum.
Bernick PE; Klimstra DS; Shia J; Minsky B; Saltz L; Shi W; Thaler H; Guillem J; Paty P; Cohen AM; Wong WD
Dis Colon Rectum; 2004 Feb; 47(2):163-9. PubMed ID: 15043285
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathological features and prognosis of gastric mixed adenoneuroendocrine carcinoma.
Wu C; Bao W; Rao Q; Wang X; Shen Q; Wei J; Dai Y; Zhou X
Int J Clin Exp Pathol; 2018; 11(3):1499-1509. PubMed ID: 31938247
[TBL] [Abstract][Full Text] [Related]
34. Prognostic implications of neuroendocrine differentiation and hormone production in patients with Stage I nonsmall cell lung carcinoma.
Pelosi G; Pasini F; Sonzogni A; Maffini F; Maisonneuve P; Iannucci A; Terzi A; De Manzoni G; Bresaola E; Viale G
Cancer; 2003 May; 97(10):2487-97. PubMed ID: 12733148
[TBL] [Abstract][Full Text] [Related]
35. CD56 expression in ovarian granulosa cell tumors, and its diagnostic utility and pitfalls.
Ohishi Y; Kaku T; Oya M; Kobayashi H; Wake N; Tsuneyoshi M
Gynecol Oncol; 2007 Oct; 107(1):30-8. PubMed ID: 17583777
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of (18)F-fluorodeoxyglucose positron emission tomography in patients with gastric neuroendocrine carcinoma and mixed adenoneuroendocrine carcinoma.
Lim SM; Kim H; Kang B; Kim HS; Rha SY; Noh SH; Hyung WJ; Cheong JH; Kim HI; Chung HC; Yun M; Cho A; Jung M
Ann Nucl Med; 2016 May; 30(4):279-86. PubMed ID: 26837515
[TBL] [Abstract][Full Text] [Related]
37. The potential role of TGFbeta1, TGFbeta2 and TGFbeta3 protein expression in colorectal carcinomas. Correlation with classic histopathologic factors and patient survival.
Tsamandas AC; Kardamakis D; Ravazoula P; Zolota V; Salakou S; Tepetes K; Kalogeropoulou C; Tsota I; Kourelis T; Makatsoris T; Karavias D; Scopa CD; Bonikos DS; Kalofonos HP; Petsas T
Strahlenther Onkol; 2004 Apr; 180(4):201-8. PubMed ID: 15057430
[TBL] [Abstract][Full Text] [Related]
38. Utility of the quantitative Ki-67 proliferation index and CD56 together in the cytologic diagnosis of small cell lung carcinoma and other lung neuroendocrine tumors.
Zheng G; Ettinger DS; Maleki Z
Acta Cytol; 2013; 57(3):281-90. PubMed ID: 23635388
[TBL] [Abstract][Full Text] [Related]
39. Neuroendocrine differentiation in extrahepatic bile duct carcinomas and its prognostic significance.
Hong SM; Kim MJ; Pi DY; Jo D; Yu E; Ro JY
Hum Pathol; 2005 Jul; 36(7):732-40. PubMed ID: 16084941
[TBL] [Abstract][Full Text] [Related]
40. Neuroendocrine differentiation in colorectal carcinomas: assessing its prognostic significance.
Atasoy P; Ensari A; Demirci S; Kurşun N
Tumori; 2003; 89(1):49-53. PubMed ID: 12729362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]